RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Haysaw, OK, I'm busted. I didn't expect anyone over on the DSCO board to actually read that post, so I carelessly let fly with the 'SD' comment. Actually, the 6 and 12 month Surfaxin stability was in fact good, but the FDA decided to move the goal posts via tighter parameters as an excuse for more delays, because they hate Capetola. But yes, ascribing an 'SD' to any bio event is foolish, especially to a regulatory event.

So you won't hear me uttering the 'SD' term around here, though 'going to the moon' is a different story - I have to have at least some fun after all the months/years of angst :o)

Plus, I really do believe this baby's -- GOING TO THE MOON! :o)